Comparative efficacy and safety of liraglutide versus metformin, naltrexone/bupropion, and phentermine-topiramate in psychiatric patients. [PDF]
Ther Adv PsychopharmacolChoi WS +4 more
europepmc +1 more source
Authors' reply to the letter to the editor regarding "Low-dose naltrexone for fibromyalgia: a re-analysis suggests lower efficacy than previously reported". [PDF]
Korean J PainHariyanto TI +3 more
europepmc +1 more source
The role of the hepatologist in the alcohol-associated liver disease epidemic. [PDF]
Hepatol CommunGómez Perdiguero G +2 more
europepmc +1 more source
Race, Ethnicity, and Language Differences in Inpatient Discharge Prescriptions for Alcohol Use Disorder at an Academic Medical Center. [PDF]
J Gen Intern MedLiauw D +4 more
europepmc +1 more source
Methodological considerations for interpreting ketamine-naltrexone trials in depression. [PDF]
Int J NeuropsychopharmacolBandeira ID +5 more
europepmc +1 more source
Intraoperative pain management for patients undergoing medication-assisted rehabilitation: a scoping review. [PDF]
BMC AnesthesiolHenriksen M, Ellingsen S, Kaldheim HKA.
europepmc +1 more source
Synergistic effects of levo-tetrahydropalmatine and low-dose naltrexone on nicotine conditioned place preference in mice: a dual-target strategy based on dopamine and opioid systems. [PDF]
Front PharmacolFeng K +7 more
europepmc +1 more source
Predictors of naltrexone prescribing for alcohol use disorder from the emergency department. [PDF]
Alcohol Clin Exp Res (Hoboken)Lebin JA +6 more
europepmc +1 more source
Identifying Extended-Release Naltrexone Treatment for Opioid Use Disorder in US Medicaid Data. [PDF]
Pharmacoepidemiol Drug SafRoss RK +5 more
europepmc +1 more source